DSA-guided vascular malformation interventional sclerosis treatment set

Abstract

The utility model discloses a DSA guided vascular malformation interventional sclerosis treatment set which comprises a sterile bag, a connecting device is installed on the outer wall of the sterile bag, a support plate is placed in the sterile bag, and two first needle cylinder clamping blocks, four second needle cylinder clamping blocks and two third needle cylinder clamping blocks are fixedly installed on the outer wall of the support plate; a hardening agent needle cylinder, a normal saline needle cylinder and a contrast agent needle cylinder are correspondingly clamped on the inner wall of the needle cylinder clamping block, an injection handle of the hardening agent needle cylinder is red, an injection handle of the normal saline needle cylinder is green, an injection handle of the contrast agent needle cylinder is blue, labels are arranged on the outer walls of the needle cylinders, and eight marking areas are arranged on the outer wall of the support plate. Errors are reduced through multiple insurances that the character labels are arranged on the outer walls of the cylinder bodies of the hardening agent needle cylinder, the normal saline needle cylinder and the contrast agent needle cylinder, the injection handle is distinguished in color, and character labeling confirmation is conducted on the labeling area on the support plate.

Description

Technical Field

[0001] The utility model relates to the technical field of interventional sclerosis treatment of vascular malformations, in particular to an interventional sclerosis treatment kit for vascular malformations under the guidance of DSA. Background Art

[0002] Sclerotherapy for vascular malformations is mainly used for vascular malformations and lymphatic malformations. Vascular malformations actually mainly include venous malformations, arteriovenous malformations, etc. Lymphatic malformations mainly include macrocystic, mixed and microcystic lymphatic malformations, which belong to the category of vascular malformations; sclerosants and contrast agents can be used for treatment at the same time. Under the guidance of medical equipment, a scalp needle is used to puncture the lesion and inject the sclerosant so that the entire lesion is filled with the sclerosant.

[0003] In the prior art, clinical syringes and scalp needles of the same specifications are used in actual treatment. In actual application, the use of sclerosants and contrast agents is confused due to the lack of differentiated identification and random placement; there is no intraoperative placement bracket, which leads to confusion on the operating table, prolonged surgical operation time, and increased risk of misuse of contrast agents and sclerosants; clinical scalp needles have a fixed length and are often unable to puncture deep venous malformations and other diseases. Using a venous puncture needle plus an extension tube instead increases the cost of consumables; the syringes and scalp needles required for intraoperative operations need to be unpacked one by one, which increases the preoperative preparation time and anesthesia time. Therefore, we propose a DSA (Digital Subtraction Angiography)-guided vascular malformation interventional sclerotherapy kit to solve the above problems. Utility Model Content

[0004] The utility model aims to solve the shortcomings in the prior art and proposes a DSA (Digital Subtraction Angiography) guided interventional sclerotherapy kit for vascular malformations.

[0005] In order to achieve the above purpose, the utility model adopts the following technical solutions:

[0006] A DSA-guided interventional sclerotherapy kit for vascular malformation comprises a sterile bag, the outer wall of which is provided with a connecting device, a support plate is placed inside the sterile bag, two first syringe blocks are fixedly mounted on the outer wall of the support plate, four second syringe blocks are fixedly mounted on the outer wall of the support plate, wherein the inner walls of two of the second syringe blocks are both clamped with large syringes of hardener, one of the second syringe blocks is clamped with a large syringe of physiological saline, and the inner wall of the other second syringe block is clamped with a large syringe of contrast agent, the injection handles of the two large syringes of hardener are both red, the injection handle of the large syringe of physiological saline is green, and the injection handle of the large syringe of contrast agent is blue, the outer walls of the large syringe of hardener, the large syringe of physiological saline and the large syringe of contrast agent are all provided with labels, the outer wall of the support plate is fixedly mounted with two third syringe blocks, and the outer wall of the support plate is provided with eight marking areas.

[0007] Preferably, a medium syringe of hardener is clamped on the inner wall of one of the two first syringe blocks, and a medium syringe of contrast agent is clamped on the inner wall of the other first syringe block; a small syringe of hardener is clamped on the inner wall of one of the two third syringe blocks, and a small syringe of contrast agent is clamped on the inner wall of the other third syringe block; the injection handle of the medium syringe of hardener is red, and the injection handle of the medium syringe of contrast agent is blue, the injection handles of the small syringe of hardener are both red, and the injection handles of the small syringe of contrast agent are blue; the outer walls of the syringes are provided with labels.

[0008] Preferably, a partition net is fixedly mounted on the outer wall of the bracket plate, and a three-way connector is placed inside the partition net.

[0009] Preferably, scalp needles of various lengths are placed inside the separator net, and the length of the scalp needles is 4-10CM.

[0010] Preferably, a pen cover is fixedly mounted on the outer wall of the bracket plate.

[0011] Preferably, a marking pen card block is fixedly installed inside the pen cover, and a sterile MARK pen is clamped on the inner wall of the marking pen card block.

[0012] Preferably, the lower half of the second syringe block is in the shape of an arc groove, and the cross-section of the upper half of the second syringe block is in the shape of an inverted eight-shaped opening to facilitate the insertion and removal of the syringe. The structures of the first syringe block, the third syringe block, and the marking pen block are the same as that of the second syringe block, only the proportions are different. The second syringe block is provided with an upper transverse rectangular groove upward, and the second syringe block is provided with a lower transverse rectangular groove downward, and the bottoms of the upper transverse rectangular groove and the lower transverse rectangular groove are lower than the bottom position of the arc groove in the lower half of the second syringe block.

[0013] Preferably, the support plate is made of plastic material, and the first syringe card block, the second syringe card block, the third syringe card block, and the marking pen card block are all made of plastic material and are integrally formed on the support plate.

[0014] Preferably, the inner walls of the two first syringe clamping blocks are both clamped with 5ML medium syringes.

[0015] Preferably, the inner walls of the two second syringe clamping blocks are clamped with 10ML large syringes.

[0016] Preferably, the inner walls of the two third syringe clamping blocks are both clamped with 2ML small syringes.

[0017] Preferably, the connecting device is a zipper or a buckle.

[0018] Compared with the prior art, the advantages of the utility model are:

[0019] This solution reduces the occurrence of errors through multiple safeguards such as text labels on the outer wall of the hardener syringe, saline syringe and contrast agent syringe, color differentiation of the injection handle, and text marking confirmation on the marking area on the bracket plate;

[0020] At the same time, this kit contains all the disposable consumables required for a sclerotherapy treatment, which can save preoperative preparation time;

[0021] This set provides a support plate to keep the surgical table clean and tidy, avoiding factors such as searching for instruments that delay surgical operations. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is a schematic cross-sectional structure diagram of a DSA-guided vascular malformation interventional sclerotherapy kit proposed by the utility model;

[0023] Figure 2 This is a three-dimensional structural schematic diagram of a DSA-guided vascular malformation interventional sclerotherapy kit proposed by the utility model;

[0024] Figure 3 This is a schematic diagram of the structure of the second syringe block of the DSA-guided vascular malformation interventional sclerosis treatment kit proposed by the utility model.

[0025] In the figure: 1. Sterile bag; 2. Zipper; 3. Support plate; 4. First syringe block; 5. Second syringe block; 6. Large syringe of hardener; 7. Large syringe of physiological saline; 8. Large syringe of contrast agent; 9. Partition net; 10. Scalp needle; 11. Three-way connector; 12. Pen cover; 13. Marking pen block; 14. Third syringe block; 15. Medium syringe of hardener; 16. Medium syringe of contrast agent; 17. Small syringe of hardener; 18. Small syringe of contrast agent; 19. Marking area; 20. Upper horizontal rectangular groove; 21. Lower horizontal rectangular groove. DETAILED DESCRIPTION

[0026] Depend on Figure 1-Figure 3 As shown, it relates to a DSA-guided interventional sclerotherapy kit for vascular malformation, including a sterile bag 1, the outer wall of which is installed with a zipper 2, the sterile bag 1 is opened and closed by the zipper 2, and a support plate 3 is placed inside the sterile bag 1, the support plate 3 can make the surgical operating table clean and tidy.

[0027] Two first syringe blocks 4 are fixedly installed on the outer wall of the bracket plate 3, and the inner walls of the two first syringe blocks 4 are both clamped with 5ML medium syringes, one of which is clamped with a hardener medium syringe 15 on its inner wall, and the other first syringe block 4 is clamped with a contrast agent medium syringe 16 on its inner wall; four second syringe blocks 5 are fixedly installed on the outer wall of the bracket plate 3, and the inner walls of the four second syringe blocks 5 are all clamped with 10ML large syringes, and the four second syringe blocks 5 fix the position of the hardener large syringe 6, the physiological saline large syringe 7 and the contrast agent large syringe 8.

[0028] The inner walls of the two second syringe blocks 5 are both clamped with large syringes of hardener 6 , the inner wall of one of the second syringe blocks 5 is clamped with a large syringe of physiological saline 7 , and the inner wall of the other second syringe block 5 is clamped with a large syringe of contrast agent 8 .

[0029] There are two third syringe blocks 14 , one of which has a small syringe of hardener 17 clamped on its inner wall, and the other of which has a small syringe of contrast agent 18 clamped on its inner wall.

[0030] The injection handles of the two large hardener syringes 6 are red, the injection handle of the large saline syringe 7 is green, and the injection handle of the large contrast agent syringe 8 is blue. The large hardener syringe 6, the large saline syringe 7 and the large contrast agent syringe 8 are distinguished by the color of the needle handles. The outer walls of the large hardener syringe 6, the large saline syringe 7 and the large contrast agent syringe 8 are all provided with labels with reagent words written on the labels.

[0031] The injection handle of the hardener medium syringe 15 is red, the injection handle of the contrast medium syringe 16 is blue, the injection handle of the hardener small syringe 17 is red, and the injection handle of the contrast medium small syringe 18 is blue; the outer walls of the syringes are all provided with labels.

[0032] Two third syringe blocks 14 are fixedly installed on the outer wall of the bracket plate 3, and the inner walls of the two third syringe blocks 14 are clamped with 2ML small syringes. The outer wall of the bracket plate 3 is provided with eight marking areas 19, and the eight marking areas 19 are respectively marked with text to distinguish two large hardener syringes 6, a large saline syringe 7, a large contrast agent syringe 8, a medium hardener syringe 15, a medium contrast agent syringe 16, a small hardener syringe 17, and a small contrast agent syringe 18.

[0033] A partition net 9 is fixedly mounted on the outer wall of the support plate 3 , and a plurality of scalp needles 10 of different lengths and models are placed inside the partition net 9 , and a three-way connector 11 is placed inside the partition net 9 .

[0034] A pen cover 12 is fixedly mounted on the outer wall of the support plate 3, a marking pen block 13 is fixedly mounted inside the pen cover 12, a sterile MARK pen is clamped on the inner wall of the marking pen block 13, and the marking pen block 13 fixes the position of the sterile MARK pen.

[0035] The lower half of the second syringe block 5 is in the shape of an arc groove, and the cross-section of the upper half of the second syringe block 5 is in the shape of an inverted eight-shaped opening. The structures of the first syringe block 4, the third syringe block 14, and the marking pen block 13 are the same as the structure of the second syringe block 5. The second syringe block 5 is provided with a transverse upper rectangular groove 20 upward, and the second syringe block 5 is provided with a transverse lower rectangular groove 21 downward. The bottoms of the transverse upper rectangular groove 20 and the transverse lower rectangular groove 21 are lower than the bottom position of the arc groove of the lower half of the second syringe block 5, so as to facilitate the syringe to be engaged with the corresponding syringe block.

[0036] Working principle: when in use, open the zipper 2 of the sterile package 1, take out the bracket plate 3, and during the surgical operation, take out the corresponding objects from the bracket plate 3 as needed, such as taking out the scalp needle 10 and the three-way connector 11 of the required length from the partition net 9, taking out the MARK pen from the marking pen block 13, and the hardener syringe of the required dose, and after injecting part of the hardener, place the large hardener syringe 6 in the corresponding second syringe block 5, so that it will not be messy and will not be taken by mistake; through the marking area 19 on the bracket plate 3 or the large hardener syringe 6, the large saline syringe 7 and the large contrast agent syringe 8, the medium hardener syringe 15, the medium contrast agent syringe 16; the small hardener syringe 17, the small contrast agent syringe 18 The text labels on the outer wall of the barrel can distinguish the hardener, contrast agent and saline text, and the color distinction on the injection handle plays a multiple reminder role to prevent the use of wrong drugs.

[0037] The above is only a preferred specific implementation of this embodiment, but the protection scope of this embodiment is not limited to this. Any technician familiar with the technical field can make equivalent replacements or changes based on the technical solution and utility model concept of this embodiment within the technical scope disclosed in this embodiment, which should be covered by the protection scope of this embodiment.

Claims

1. A DSA-guided interventional sclerotherapy kit for vascular malformation, comprising a sterile bag (1), characterized in that: The outer wall of the sterile bag (1) is provided with a connecting device, a support plate (3) is placed inside the sterile bag (1), two first syringe clamps (4) are fixedly installed on the outer wall of the support plate (3), and four second syringe clamps (5) are fixedly installed on the outer wall of the support plate (3), wherein the inner walls of two of the second syringe clamps (5) are clamped with large syringes of hardener (6), the inner wall of one of the second syringe clamps (5) is clamped with a large syringe of physiological saline (7), and the inner wall of the other second syringe clamp is clamped with a large syringe of saline (8). The inner wall of the bracket plate (5) is clamped with a large contrast agent syringe (8), the injection handles of the two hardener large syringes (6) are both red, the injection handle of the saline large syringe (7) is green, and the injection handle of the contrast agent large syringe (8) is blue. The outer walls of the hardener large syringe (6), the saline large syringe (7) and the contrast agent large syringe (8) are all provided with labels. The outer wall of the bracket plate (3) is fixedly mounted with two third syringe clamps (14), and the outer wall of the bracket plate (3) is provided with eight marking areas (19).

2. A DSA-guided vascular malformation interventional sclerotherapy kit according to claim 1, characterized in that: The inner wall of one of the two first syringe blocks (4) is clamped with a hardener medium syringe (15), and the inner wall of the other first syringe block (4) is clamped with a contrast medium medium syringe (16); the inner wall of one of the two third syringe blocks (14) is clamped with a hardener small syringe (17), and the inner wall of the other third syringe block (14) is clamped with a contrast medium small syringe (18); the injection handle of the hardener medium syringe (15) is red, the injection handle of the contrast medium syringe (16) is blue, the injection handle of the hardener small syringe (17) is red, and the injection handle of the contrast medium small syringe (18) is blue; the outer walls of the syringes are all provided with labels.

3. The DSA-guided interventional sclerotherapy kit for vascular malformation according to claim 1, characterized in that: A partition net (9) is fixedly mounted on the outer wall of the support plate (3), and a three-way connector (11) is placed inside the partition net (9).

4. A DSA-guided vascular malformation interventional sclerotherapy kit according to claim 3, characterized in that: Scalp needles (10) of various lengths are placed inside the partition net (9), and the length of the scalp needles is 4-10 cm.

5. The DSA-guided interventional sclerotherapy kit for vascular malformation according to claim 1, characterized in that: A pen cover (12) is fixedly mounted on the outer wall of the support plate (3).

6. A DSA-guided vascular malformation interventional sclerotherapy kit according to claim 5, characterized in that: A marking pen card block (13) is fixedly installed inside the pen cover (12), and a sterile MARK pen is clamped on the inner wall of the marking pen card block (13).

7. The DSA-guided interventional sclerotherapy kit for vascular malformation according to claim 5, characterized in that: The lower half of the second syringe block (5) is in the shape of an arc groove, and the cross section of the upper half of the second syringe block (5) is in the shape of an inverted eight-shaped opening. The structures of the first syringe block (4), the third syringe block (14) and the marking pen block (13) are the same as the structure of the second syringe block (5). The second syringe block (5) is provided with an upper transverse rectangular groove (20) facing upward, and the second syringe block (5) is provided with a lower transverse rectangular groove (21) facing downward. The bottoms of the upper transverse rectangular groove (20) and the lower transverse rectangular groove (21) are lower than the bottom position of the arc groove of the lower half of the second syringe block (5).

8. The DSA-guided interventional sclerotherapy kit for vascular malformation according to claim 1, characterized in that: The inner walls of the two first syringe blocks (4) are both clamped with 5ML medium syringes, the inner walls of the two second syringe blocks (5) are both clamped with 10ML large syringes, and the inner walls of the two third syringe blocks (14) are both clamped with 2ML small syringes.

9. The DSA-guided interventional sclerotherapy kit for vascular malformation according to claim 1, characterized in that: The connecting device is a zipper (2) or a buckle.

Images